Table: Cyfuse Biomedical - 9-MTH parent results

Cyfuse Biomedical KK

14/11/2023 06:30

Nov 14 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            29 mln              340 mln           51 mln     
                 (-91.3 pct)                           (-86.2 pct)  
  Operating     loss 528 mln        loss 249 mln      loss 783 mln  
  Recurring     loss 532 mln        loss 232 mln      loss 672 mln  
  Net           loss 534 mln        loss 272 mln      loss 675 mln  
  EPS          loss 68.47 yen      loss 193.26 yen   loss 86.48 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T